Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARTEOLOL vs CEDIRANIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CARTEOLOL vs CEDIRANIB: Safety Overview

Metric CARTEOLOL CEDIRANIB
Total FAERS Reports 318 130
Deaths Reported 30 27
Death Rate 9.4% 20.8%
Hospitalizations 93 71
Average Patient Age 67.5 yrs 61.2 yrs
% Female Patients 56.6% 62.3%
FDA Approval Date Dec 28, 1988 N/A
Manufacturer Sandoz Inc N/A
Route OPHTHALMIC N/A
Marketing Status Discontinued N/A